PI3KI´ Inhibitor Idelalisib Inhibits AKT Signaling In Myelofibrosis Patients On Chronic JAK Inhibitor Therapy »
04/09/14

Update On The Safety and Efficacy Of The Pan Class I PI3K Inhibitor SAR245408 (XL147) In Chronic Lymphocytic Leukemia and Non-Hodgkina€™s Lymphoma Patients »
04/09/14

PKC Inhibitor AEB071 Demonstrates Pre-Clinical Activity In Chronic Lymphocytic Leukemia »
04/09/14

Inhibitors Of B-Cell Receptor Molecules Affect Surface CD20 and Impair Antitumor Activity Of Anti-CD20 Monoclonal Antibodies »
04/09/14

ZAP70 Methylation Is An Independent Prognostic Biomarker For Front Line Therapy Of Chronic Lymphocytic Leukemia: Results From The UK LRF CLL4 Trial »
04/09/14

Dual PI3KI´/I3 Inhibition By RP6530 Induces Apoptosis and Cytotoxicity In B-Lymphoma Cells »
04/09/14

Response To 1st-Line Treatment With BR Or FCR In Patients With Chronic Lymphocytic Leukaemia: First Outcome Data From The German Prospective TLN Registry »
04/09/14

The Incidence and Risk Factors For Hematological Malignancies and Premalignant Hematological Disorders In HIV. »
04/09/14

A Multicentre Retrospective UK Study Detailing Onset Of GvHD, Responses To Treatment and Outcome After Donor Lymphocyte Infusion Following Haemopoietic Stem Cell Transpantation: Rates Of GvHD Are High But Death From GvHD Infrequent. »
04/09/14

Ibrutinib Inhibits B-Cell Adhesion and Causes An Efflux Of Chronic Lymphocytic Leukemia Cells From The Tissue Microenvironment Into The Blood Leading To a Transient Treatment-Induced Lymphocytosis. »
04/09/14